Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
OriginatorRoute 1Steps 7 · Total yield 16.6 g
OLME-0011187-42-4→OLME-00243083-12-1→OLME-00351802-42-7→OLME-004144689-94-1→OLME-005144689-93-0→OLME-006124750-51-2→OLME-007144690-33-5→OLME-0081114761-92-0→OLME-00980841-78-7→OLME-010144690-92-6→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| OLME-001 | 1187-42-4 | (2R,3R,4R,5S)-2-((benzoyloxy)methyl)-5-bromotetrahydrofuran-3,4-diyl dibenzoate |
| OLME-002 | 43083-12-1 | 1,1,1-trimethoxybutane |
| OLME-003 | 51802-42-7 | 2-propyl-1H-imidazole-4,5-dicarbonitrile |
| OLME-004 | 144689-94-1 | diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate |
| OLME-005 | 144689-93-0 | ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
| OLME-006 | 124750-51-2 | 5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
| OLME-007 | 144690-33-5 | ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate |
| OLME-008 | 1114761-92-0 | lithium 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate |
| OLME-009 | 80841-78-7 | 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one |
| OLME-010 | 144690-92-6 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate |
OptimisedRoute 2Steps 5 · Total yield /
OLME-004144689-94-1→OLME-005144689-93-0→OLME-00980841-78-7→OLME-010144690-92-6→OLME-011114772-54-2→OLME-012144690-96-0→OLME-013144689-24-7→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| OLME-004 | 144689-94-1 | diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate |
| OLME-005 | 144689-93-0 | ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
| OLME-009 | 80841-78-7 | 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one |
| OLME-010 | 144690-92-6 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate |
| OLME-011 | 114772-54-2 | 4'-(bromomethyl)-[1,1'-biphenyl]-2-carbonitrile |
| OLME-012 | 144690-96-0 | ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
| OLME-013 | 144689-24-7 | 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid |
OptimisedRoute 3Steps 3 · Total yield /
OLME-005144689-93-0→OLME-006124750-51-2→OLME-00980841-78-7→OLME-010144690-92-6→OLME-014144690-04-0→OLME-015—→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| OLME-005 | 144689-93-0 | ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
| OLME-006 | 124750-51-2 | 5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
| OLME-009 | 80841-78-7 | 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one |
| OLME-010 | 144690-92-6 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate |
| OLME-014 | 144690-04-0 | 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid |
| OLME-015 | - | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
OptimisedRoute 4Steps 5 · Total yield 40 mg
OLME-005144689-93-0→OLME-00980841-78-7→OLME-016589-15-1→OLME-017685091-51-4→OLME-018—→OLME-019—→OLME-020—→OLME-021—→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| OLME-005 | 144689-93-0 | ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
| OLME-009 | 80841-78-7 | 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one |
| OLME-016 | 589-15-1 | 1-bromo-4-(bromomethyl)benzene |
| OLME-017 | 685091-51-4 | ethyl 1-(4-bromobenzyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
| OLME-018 | - | (2-(1-(2-phenylpropan-2-yl)-1H-tetrazol-5-yl)phenyl)boronic acid |
| OLME-019 | - | ethyl 4-(2-hydroxypropan-2-yl)-1-((2'-(1-(2-phenylpropan-2-yl)-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-propyl-1H-imidazole-5-carboxylate |
| OLME-020 | - | 4-(2-hydroxypropan-2-yl)-1-((2'-(1-(2-phenylpropan-2-yl)-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-propyl-1H-imidazole-5-carboxylic acid |
| OLME-021 | - | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-1-((2'-(1-(2-phenylpropan-2-yl)-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-propyl-1H-imidazole-5-carboxylate |
OptimisedRoute 5Steps 5 · Total yield /
OLME-00980841-78-7→OLME-011114772-54-2→OLME-022—→OLME-023—→OLME-0241309566-95-7→OLME-0251199807-52-7→OLME-0261993494-83-9→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| OLME-009 | 80841-78-7 | 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one |
| OLME-011 | 114772-54-2 | 4'-(bromomethyl)-[1,1'-biphenyl]-2-carbonitrile |
| OLME-022 | - | 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carbonitrile |
| OLME-023 | - | 4,4-dimethyl-2-propyl-4,6-dihydro-1H-furo[3,4-d]imidazol-6-ol |
| OLME-024 | 1309566-95-7 | 4'-((6-hydroxy-4,4-dimethyl-2-propyl-4,6-dihydro-1H-furo[3,4-d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile |
| OLME-025 | 1199807-52-7 | 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid |
| OLME-026 | 1993494-83-9 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
OptimisedRoute 1Steps 3 · Total yield /
(I)109067-1-a638-07-3→(II)109067-1-a1517-05-1→(III)109067-1-a88150-45-2→(IV)109067-1-a14205-39-1→(V)109067-1-a89-98-5→(VI)109067-1-a88150-46-3→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-1-a | 638-07-3 | Ethyl 4-chloro-3-oxobutanoate |
| (II)109067-1-a | 1517-05-1 | 2-azidoethan-1-ol |
| (III)109067-1-a | 88150-45-2 | ethyl 4-(2-azidoethoxy)-3-oxobutanoate |
| (IV)109067-1-a | 14205-39-1 | 3-Amino-2-butenoic acid methyl ester |
| (V)109067-1-a | 89-98-5 | 2-Chlorobenzaldehyde |
| (VI)109067-1-a | 88150-46-3 | 3-ethyl 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 2Steps 4 · Total yield /
(I)109067-2-a638-07-3→(II)109067-2-a2222844-70-2→(III)109067-2-a3891-07-4→(IV)109067-2-a88150-75-8→(V)109067-2-a—→(VI)109067-2-a1170036-31-3→(VII)109067-2-a103094-30-0,88150-62-3→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-2-a | 638-07-3 | Ethyl 4-chloro-3-oxobutanoate |
| (II)109067-2-a | 2222844-70-2 | Ethyl 4-[(4-methylbenzene-1-sulfonyl)oxy]-3-oxobutanoate |
| (III)109067-2-a | 3891-07-4 | N-(2-Hydroxyethyl)phthalimide |
| (IV)109067-2-a | 88150-75-8 | Ethyl 4-(2-phthalimidoethoxy)acetoacetate |
| (V)109067-2-a | - | Ethyl (2Z)-3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]but-2-enoate |
| (VI)109067-2-a | 1170036-31-3 | Methyl (2Z)-2-[(2-chlorophenyl)methylidene]-3-oxobutanoate |
| (VII)109067-2-a | 103094-30-0,88150-62-3 | 3-Ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 3Steps 3 · Total yield /
(I)109067-3-a638-07-3→(II)109067-3-a1517-05-1→(III)109067-3-a88150-45-2→(IV)109067-3-a1170036-31-3→(V)109067-3-a88150-46-3→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-3-a | 638-07-3 | 4-Chloro-3-oxobutyric acid ethyl ester |
| (II)109067-3-a | 1517-05-1 | 2-azidoethan-1-ol |
| (III)109067-3-a | 88150-45-2 | ethyl 4-(2-azidoethoxy)-3-oxobutanoate |
| (IV)109067-3-a | 1170036-31-3 | Methyl (2Z)-2-[(2-chlorophenyl)methylidene]-3-oxobutanoate |
| (V)109067-3-a | 88150-46-3 | 3-ethyl 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 4Steps 6 · Total yield /
(I)109067-4-a6065-82-3→(II)109067-4-a621-63-6→(III)109067-4-a638-07-3→(IV)109067-4-a225939-10-6→(V)109067-4-a89-98-5→(VI)109067-4-a—→(VII)109067-4-a14205-39-1→(VIII)109067-4-a194472-23-6→(IX)109067-4-a—→(X)109067-4-a—→(XI)109067-4-a1170036-31-3→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-4-a | 6065-82-3 | Diethoxyacetic acid ethyl ester |
| (II)109067-4-a | 621-63-6 | 2,2-Diethoxyethanol |
| (III)109067-4-a | 638-07-3 | 4-Chloro-3-oxobutyric acid ethyl ester |
| (IV)109067-4-a | 225939-10-6 | ethyl 4-(2,2-diethoxyethoxy)-3-oxobutanoate |
| (V)109067-4-a | 89-98-5 | 2-Chlorobenzaldehyde |
| (VI)109067-4-a | - | ethyl (2Z)-2-[(2-chlorophenyl)methylidene]-4-(2,2-dimethoxyethoxy)-3-oxobutanoate |
| (VII)109067-4-a | 14205-39-1 | Methyl 3-amino-2-butenoate |
| (VIII)109067-4-a | 194472-23-6 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[(2,2-dimethoxyethoxy)methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (IX)109067-4-a | - | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[(2E)-2-(hydroxyimino)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (X)109067-4-a | - | ethyl (2E)-3-amino-4-(2,2-diethoxyethoxy)but-2-enoate |
| (XI)109067-4-a | 1170036-31-3 | Methyl (2Z)-2-[(2-chlorophenyl)methylidene]-3-oxobutanoate |
OptimisedRoute 5Steps 4 · Total yield /
(I)109067-5-a141-43-5→(II)109067-5-a33885-01-7→(III)109067-5-a24070-16-4→(IV)109067-5-a638-07-3→(V)109067-5-a156366-26-6→(VI)109067-5-a89-98-5→(VII)109067-5-a14205-39-1→(VIII)109067-5-a156366-27-7→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-5-a | 141-43-5Available | 2-Aminoethanol |
| (II)109067-5-a | 33885-01-7 | (2-chloro-1,1-diphenylethyl)benzene |
| (III)109067-5-a | 24070-16-4 | 2-[(triphenylmethyl)amino]ethan-1-ol |
| (IV)109067-5-a | 638-07-3 | Ethyl 4-chloroacetoacetate |
| (V)109067-5-a | 156366-26-6 | ethyl 3-oxo-4-{2-[(triphenylmethyl)amino]ethoxy}butanoate |
| (VI)109067-5-a | 89-98-5 | 2-Chlorobenzaldehyde |
| (VII)109067-5-a | 14205-39-1 | 3-Amino-2-butenoic acid methyl ester |
| (VIII)109067-5-a | 156366-27-7 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-({2-[(triphenylmethyl)amino]ethoxy}methyl)-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 6Steps 8 · Total yield /
(I)109067-6-a1517-05-1→(II)109067-6-a79-11-8→(III)109067-6-a79598-48-4→(IV)109067-6-a2033-24-1→(V)109067-6-a109-78-4→(VI)109067-6-a103069-47-2→(VII)109067-6-a89-98-5→(VIII)109067-6-a14205-39-1→(IX)109067-6-a134471-46-8→(X)109067-6-a134471-71-9→(XI)109067-6-a66051-01-2→(XII)109067-6-a—→(XIII)109067-6-a103094-34-4→(XIV)109067-6-a125711-60-6→(XV)109067-6-a103129-82-4→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-6-a | 1517-05-1 | 2-azidoethan-1-ol |
| (II)109067-6-a | 79-11-8 | 2-Chloroacetic acid |
| (III)109067-6-a | 79598-48-4 | 2-(2-azidoethoxy)acetic acid |
| (IV)109067-6-a | 2033-24-1 | 2,2-Dimethyl-1,3-dioxane-4,6-dione |
| (V)109067-6-a | 109-78-4Available | 3-Hydroxypropionitrile |
| (VI)109067-6-a | 103069-47-2 | 2-cyanoethyl 4-(2-azidoethoxy)-3-oxobutanoate |
| (VII)109067-6-a | 89-98-5 | 2-Chlorobenzaldehyde |
| (VIII)109067-6-a | 14205-39-1 | 3-Amino-2-butenoic acid methyl ester |
| (IX)109067-6-a | 134471-46-8 | 3-(2-cyanoethyl) 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (X)109067-6-a | 134471-71-9 | 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine-3-carboxylic acid |
| (XI)109067-6-a | 66051-01-2 | (2S)-2-methoxy-2-phenylethan-1-ol |
| (XII)109067-6-a | - | 3-(2S)-2-methoxy-2-phenylethyl 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (XIII)109067-6-a | 103094-34-4 | 3-[(2S)-2-Methoxy-2-phenylethyl] 5-methyl (4S)-2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (XIV)109067-6-a | 125711-60-6 | 3-Ethyl 5-methyl (4S)-2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (XV)109067-6-a | 103129-82-4 | 3-Ethyl 5-methyl (4S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 7Steps 6 · Total yield /
(I)109067-8-a—→(II)109067-8-a,(II)109067-8-b638-07-3→(III)109067-8-a194472-29-2→(IV)109067-8-a,(IV)109067-8-b89-98-5→(V)109067-8-a,(V)109067-8-b14205-39-1→(VI)109067-8-a194472-10-1→(VII)109067-8-a194472-12-3→(VIII)109067-8-a,(VIII)109067-8-b194472-14-5→(IX)109067-8-a,(IX)109067-8-b—→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-8-a | - | [5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol |
| (II)109067-8-a,(II)109067-8-b | 638-07-3 | 4-Chloro-3-oxobutyric acid ethyl ester |
| (III)109067-8-a | 194472-29-2 | ethyl 4-({5-[(4-ethoxy-2,4-dioxobutoxy)methyl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)-3-oxobutanoate |
| (IV)109067-8-a,(IV)109067-8-b | 89-98-5 | 2-Chlorobenzaldehyde |
| (V)109067-8-a,(V)109067-8-b | 14205-39-1 | 3-Amino-2-butenoic acid methyl ester |
| (VI)109067-8-a | 194472-10-1 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-({[5-({[4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridin-2-yl]methoxy}methyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy}methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (VII)109067-8-a | 194472-12-3 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[(4-{[4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridin-2-yl]methoxy}-2,3-dihydroxybutoxy)methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (VIII)109067-8-a,(VIII)109067-8-b | 194472-14-5 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-[(2-oxoethoxy)methyl]-1,4-dihydropyridine-3,5-dicarboxylate |
| (IX)109067-8-a,(IX)109067-8-b | - | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[(2E)-2-(hydroxyimino)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 8Steps 4 · Total yield /
(II)109067-8-a,(II)109067-8-b638-07-3→(IV)109067-8-a,(IV)109067-8-b89-98-5→(V)109067-8-a,(V)109067-8-b14205-39-1→(VIII)109067-8-a,(VIII)109067-8-b194472-14-5→(IX)109067-8-a,(IX)109067-8-b—→(X)109067-8-b22323-82-6→(XI)109067-8-b110464-45-4→(XII)109067-8-b—→(XIII)109067-8-b194472-30-5→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (II)109067-8-a,(II)109067-8-b | 638-07-3 | 4-Chloro-3-oxobutyric acid ethyl ester |
| (IV)109067-8-a,(IV)109067-8-b | 89-98-5 | 2-Chlorobenzaldehyde |
| (V)109067-8-a,(V)109067-8-b | 14205-39-1 | 3-Amino-2-butenoic acid methyl ester |
| (VIII)109067-8-a,(VIII)109067-8-b | 194472-14-5 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-[(2-oxoethoxy)methyl]-1,4-dihydropyridine-3,5-dicarboxylate |
| (IX)109067-8-a,(IX)109067-8-b | - | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[(2E)-2-(hydroxyimino)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (X)109067-8-b | 22323-82-6 | [(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methanol |
| (XI)109067-8-b | 110464-45-4 | ethyl 4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-oxobutanoate |
| (XII)109067-8-b | - | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (XIII)109067-8-b | 194472-30-5 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[(2,3-dihydroxypropoxy)methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 9Steps 5 · Total yield /
(I)109067-9-a23326-27-4→(II)109067-9-a100-46-9→(III)109067-9-a24405-35-4→(IV)109067-9-a—→(V)109067-9-a39562-06-6→(VI)109067-9-a1309115-67-0→(VII)109067-9-a1517-05-1→(VIII)109067-9-a—→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)109067-9-a | 23326-27-4 | 2-Butynoic acid methyl ester |
| (II)109067-9-a | 100-46-9Available | 1-Phenylmethylamine |
| (III)109067-9-a | 24405-35-4 | ethyl (2Z)-2-[(2-chlorophenyl)methylidene]-3-oxobutanoate |
| (IV)109067-9-a | - | 3-methyl 5-propyl 1-benzyl-4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (V)109067-9-a | 39562-06-6 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (VI)109067-9-a | 1309115-67-0 | 3-ethyl 5-methyl 2-(bromomethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| (VII)109067-9-a | 1517-05-1 | 2-azidoethan-1-ol |
| (VIII)109067-9-a | - | 3-methyl 5-propyl 6-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-2-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
OptimisedRoute 10Steps 2 · Total yield /
(I)158395-3-a2032-35-1→(II)158395-3-a—→(III)158395-3-a621-63-6→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)158395-3-a | 2032-35-1 | 2-Bromo-1,1-diethoxyethane |
| (II)158395-3-a | - | 2,2-Diethoxyethyl acetate |
| (III)158395-3-a | 621-63-6 | 2,2-Diethoxyethanol |
OptimisedRoute 11Steps 1 · Total yield /
(I)180072-57-a674-82-8→(II)180072-57-a—→API · Olmesartan Medoxomil/Amlodipine orotate
| Code | CAS No. | Intermediate |
|---|
| (I)180072-57-a | 674-82-8Available | 4-Methyleneoxetan-2-one |
| (II)180072-57-a | - | 4-Chloro-3-oxobutanoic acid |